|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06826 HAOHAI BIOTEC
Nominal 
16.730 +0.229 (+1.388%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 1,165,842 | -9.809% | 1,292,636 | 1,397,112 | 1,305,707 | 956,267 |
| Cost of Sales | (406,254) | 5.149% | (386,361) | (413,817) | (379,291) | (289,484) |
| Gross Profit | 759,588 | -16.186% | 906,275 | 983,295 | 926,416 | 666,783 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 75 | -- | (2,166) | 473 | (4,594) | (8,615) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (328) | 429.032% | (62) | 305 | 326 | 1,501 | |
| Profit / (Loss) before Taxation | 132,583 | -43.733% | 235,630 | 262,492 | 249,797 | 97,427 | |
| Taxation | (22,063) | -35.042% | (33,965) | (44,834) | (41,110) | (23,337) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,107 | -77.585% | 9,400 | 17,625 | (3,452) | (3,060) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 112,627 | -46.639% | 211,065 | 235,283 | 205,235 | 71,030 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (18,949) | -30.823% | (27,392) | (29,236) | (35,438) | (40,723) |
| Depreciation & Amortisation | 114,005 | 10.321% | 103,339 | 98,572 | 101,774 | 96,839 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 49.000 | -46.154% | 91.000 | 101.000 | 86.000 | 29.286 |
| DPS (cts) | 25.000 | -- | 40.000 | 40.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 51.020% | -- | 43.956% | 39.604% | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 23.571 | -- | 24.468 | 25.433 | 23.810 | 22.504315 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 112,627 |
| %Change | -46.639% |
| EPS / (LPS) | RMB 0.490 |
| NBV Per Share (¥) | RMB 23.571 |